Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Communication between primary-care physicians and patients can reduce medication-related problems

25.01.2005


Primary-care physicians who encourage their patients to let them know about bothersome side effects of prescribed medications –– and who address such problems promptly –– can reduce the chances that patients will be harmed by the medications, according to a new study by researchers in Boston.



The study results, published in the Jan. 24 issue of the Archives of Internal Medicine, will help researchers develop strategies for decreasing the number of adverse drug events (ADEs) –– instances of injury arising from prescription medicines –– in patients across the country, the authors suggest.

"In an earlier study, we tracked ADEs in a group of patients being treated in primary-care practices. We expected that the same percentage of outpatients would have ADEs as had been found in studies of hospitalized patients –– about 7 percent," says the study’s lead author, Saul N. Weingart, M.D., Ph.D., director of the Center for Patient Safety at Dana-Farber Cancer Institute. He conducted the research while on staff at Beth Israel Deaconess Medical Center. "We were astounded to find the actual rate was 25 percent, and that many of the ADEs were preventable. In the new study, we wanted to see the extent to which doctor/patient communication about patients’ medication symptoms resulted in such incidents."


David W. Bates, MD, MSc, of Brigham and Women’s Hospital, is the study’s senior author. The investigators were based at Beth Israel Deaconess Medical Center, Brigham and Women’s Hospital, and the Harvard School of Public Health.

The study involved 661 patients at four adult primary-care practices in Boston. Researchers interviewed patients and reviewed their medical records to tally the number of ADEs reported over a three-month period. They also surveyed physicians whose patients experienced medication-related symptoms. A panel of physicians and pharmacists reviewed each reported symptom to determine whether it constituted a true adverse drug event.

The researchers found that while many patients experienced ADEs, they failed to report a surprising number of them –– 31 percent –– to their physicians. And while physicians often did change the therapies of patients who reported medication problems, they didn’t order such changes 24 percent of the time. "For every symptom that patients experienced but failed to report, one in five resulted in an adverse drug event that could have been prevented or been made less severe," Weingart says. "For every symptom that patients did report but doctors failed to act on, two-thirds resulted in an adverse drug event."

The investigators also found that patients who were taking several medications and had allergies to multiple medications were more likely to report symptoms to their doctors. Male physicians and physicians who worked at two practices were more likely than average to change therapies.

The investigators didn’t inquire into patients’ reasons for not reporting some of the adverse side effects they experienced. They speculate, however, that patients may have been reticent about discussing side effects that were either common or relatively mild, or that were embarrassing (such as diarrhea or sexual dysfunction). And although doctors were not asked why they didn’t change medications in some cases, the researchers say doctors may have decided that side effects were tolerable after discussing them with patients. "In cases where doctors did change a medication in response to a patient’s symptoms, we found that the number of adverse drug events was very small," notes Weingart, who is an assistant professor of medicine at Harvard Medical School.

The vast majority of ADEs that occurred during the study were not dangerous, he continues, "but 12 percent of them were considered serious; that is, they could have caused significant problems such as organ damage or bleeding had they not been corrected."

The ’moral’ of the study is that "patients have a lot to tell us about symptoms they experience due to their medications," Weingart observes. "And there is a great deal of opportunity for doctors to prevent harm by asking questions regularly about medications and medication-related problems, and by taking patients’ comments seriously." Weingart and his colleagues are currently exploring whether technological tools, such as e-mail reminder messages, can encourage patients to report side effects to their physicians.

Bill Schaller | EurekAlert!
Further information:
http://www.dfci.harvard.edu

More articles from Health and Medicine:

nachricht Laser activated gold pyramids could deliver drugs, DNA into cells without harm
24.03.2017 | Harvard John A. Paulson School of Engineering and Applied Sciences

nachricht What does congenital Zika syndrome look like?
24.03.2017 | University of California - San Diego

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>